HIT Consultant July 31, 2024
Gav Martell, VP of Business Development & Co-founder at Yonalink

The Need to Address Accessibility Gaps

Clinical trials are a driving force of medical innovation. However, they are predominantly conducted in large urban hospitals that have larger staff and more resources, which puts trial participation out of reach for the majority of Americans who live outside of major city centers. Despite having as much interest as city-dwellers, these individuals often find participation in clinical trials nearly impossible due to daunting travel, logistical and financial challenges. Alarmingly, three out of four cancer patients eager to participate in clinical trials are thwarted by these barriers.

This lack of accessibility not only exacerbates existing healthcare disparities but also prevents underserved communities from accessing potentially life-saving treatments. The inadvertent exclusion of communities that...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Equity/SDOH, Healthcare System, Patient / Consumer, Trends
Key Lead Generation Providers and Technology Solutions for the Clinical Trials Industry
Google DeepMind CEO: AI-Designed Drugs Coming to Clinical Trials in 2025
CEPI provides $6.2m to push first mRNA-based Rift Valley fever vaccine into trial
Large study points to benefits - and risks - of GLP-1 drugs
Clinical Trials Arena Excellence Awards 2024 – Winners Announced!

Share This Article